You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KSHV-MCD

Showing 1 - 25 of 58
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

KSHV Inflammatory Cytokine Syndrome (KICS), Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease Trial run by

Not yet recruiting
  • KSHV Inflammatory Cytokine Syndrome (KICS)
  • Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 2, 2023

Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

Active, not recruiting
  • Lymphoproliferative Disorder
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Castleman Disease, Multicentric Castleman Disease, Giant Lymph Node Hyperplasia Trial run by the NCI (Zidovudine, Tocilizumab,

Completed
Has Results
  • Castleman Disease
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 8, 2020

Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, DLBCL Trial in Kampala (Rituximab and Hyaluronidase Human,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Rituximab and Hyaluronidase Human
  • +8 more
  • Kampala, Uganda
    UCI-Fred Hutch Cancer Centre
Mar 9, 2022

Multicentric Castleman Disease Trial in Lilongwe (Rituximab, Etoposide)

Recruiting
  • Multicentric Castleman Disease
  • Lilongwe, Malawi
    UNC Project, Kamuzu Central Hospital
May 2, 2022

s From HIV Infection, KSHV Infection, Viral-Related

Recruiting
  • HIV
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Focal Segmental Glomerulosclerosis and Minimal Change Disease

    Not yet recruiting
    • Focal Segmental Glomerulosclerosis
    • +3 more
    • Biospecimen collection
    • Data collection
    • Ann Arbor, Michigan
      University of Michigan
    Dec 6, 2022

    SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19

    Completed
    • SARS-CoV Infection
    • +3 more
    • Moderna COVID-19 Vaccine
    • +2 more
    • Tucson, Arizona
    • +28 more
    Sep 19, 2022

    Free Mucogingival Grafts, Gingival Recession, Root Coverage Trial in Murcia (Buccal muco-gingival tissue graft, Palatal

    Recruiting
    • Free Mucogingival Grafts
    • +3 more
    • Buccal muco-gingival tissue graft
    • Palatal connective tissue graft
    • Murcia, Spain
      Centro Odontologico Del Sureste Slp
    May 6, 2023

    Diffuse Large B Cell Lymphoma (DLBCL) Trial in Shanghai (Orelabrutinib + R-CHOP, Placebo + R-CHOP)

    Recruiting
    • Diffuse Large B Cell Lymphoma (DLBCL)
    • Orelabrutinib + R-CHOP
    • Placebo + R-CHOP
    • Shanghai, Shanghai, China
      Shanghai Ruijing Hospital
    Nov 28, 2022

    A Study of Rituximab in Frontline Therapy for Glomerulonephritis

    Recruiting
    • Glomerulonephritis
      • Shanghai, China
      • +4 more
      Feb 27, 2023

      Minimal Change Disease, Focal Segmental Glomerulosclerosis Trial in United States (VB119)

      Recruiting
      • Minimal Change Disease
      • Focal Segmental Glomerulosclerosis
      • Los Angeles, California
      • +7 more
      Jul 19, 2022

      Kidney Diseases, Diabetic Nephropathies, Glomerulosclerosis, Focal Segmental Trial in United States (GFB-887, Placebo)

      Recruiting
      • Kidney Diseases
      • +10 more
      • Birmingham, Alabama
      • +75 more
      Mar 29, 2022

      Kidney Disease Trial run by the NIDDK (N-acetyl D-mannosamine)

      Completed
      • Kidney Disease
      • N-acetyl D-mannosamine
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      Orelabrutinib in Combination With Standard Treatment Regimen for

      Not yet recruiting
      • Lymphoma, Large B-Cell, Diffuse Neoplasms by Histologic Type
      • Nanjing, Jiangsu, China
        Hematological Department, People's Hospital of Jiangsu Province
      Aug 23, 2023

      FSGS, MCD, Focal Segmental Glomerulosclerosis Trial in United States (adalimumab)

      Recruiting
      • FSGS
      • +3 more
      • Ann Arbor, Michigan
      • +3 more
      Jan 31, 2022

      Risk Factors for Non-HIV-Related Kaposi s Sarcoma

      Completed
      • Kaposi's Sarcoma
        • Palermo, Italy
          Universita Degli Studi Di Palermo
        Mar 11, 2021

        Classical Lissencephalies and Subcortical Band Heterotopias Trial in Jette (Venipuncture and skin biopsy for RNA extraction)

        Not yet recruiting
        • Classical Lissencephalies and Subcortical Band Heterotopias
        • Venipuncture and skin biopsy for RNA extraction
        • Jette, Brussel, Belgium
          UZ Brussel
        Jan 7, 2022

        Microvascular Coronary Dysfunction Trial in Los Angeles (Handgrip, Altitude simulation, Leg exercise)

        Recruiting
        • Microvascular Coronary Dysfunction
        • Handgrip
        • +2 more
        • Los Angeles, California
          Cedars-Sinai Medical Center
        Aug 17, 2021

        Nephrotic Syndrome Study Network

        Recruiting
        • Minimal Change Disease (MCD)
        • +2 more
        • Kidney Biopsy
        • Los Angeles, California
        • +34 more
        Jan 3, 2022

        Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Idiopathic Nephrotic Syndrome Trial in Cologne (Biosampling)

        Recruiting
        • Glomerulosclerosis, Focal Segmental
        • +2 more
        • Biosampling
        • Cologne, NRW, Germany
          University Hospital of Cologne
        Nov 12, 2021

        Rituximab for Refractory or Relapsed Focal Segmental

        Completed
        • Focal Segmental Glomerulosclerosis
        • Minimal Change Disease
          • Istanbul, Turkey
            Istanbul University
          Nov 28, 2020

          Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease, Primary Effusion Lymphoma Trial (Pomalidomide,

          Withdrawn
          • Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease
          • Primary Effusion Lymphoma
          • (no location specified)
          Aug 29, 2018

          Nephrotic Syndrome Trial in Ranica (Blood sampling)

          Recruiting
          • Nephrotic Syndrome
          • Blood sampling
          • Ranica, BG, Italy
            Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
          Jan 25, 2023

          Viral Associated Malignancies, Kaposi Sarcoma, EBV/KSHV-associated Lymphomas Trial run by the NCI (Pomalidomide, Nivolumab)

          Recruiting
          • Viral Associated Malignancies
          • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jul 20, 2022